Market revenue in 2024 | USD 42.4 million |
Market revenue in 2030 | USD 44.7 million |
Growth rate | 0.9% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.48% in 2024. Horizon Databook has segmented the Denmark hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The Hospital-Acquired Infections (HAI) diagnostics market in Denmark is characterized by rise of infections, for instance, in August 2024, Statens Serum Institut (SSI) reported a significant increase in infections caused by carbapenemase-producing Enterobacterales (CPE) within Danish hospitals.
From 2022 to 2023, cases rose by 43%, totaling 436 reported instances. Previously associated with international travel or hospitalization abroad, these multidrug-resistant bacteria are now spreading domestically, independent of foreign sources presence of well-established global players and local companies leveraging advanced diagnostic solutions.
These companies benefit from Denmark's robust healthcare infrastructure and its commitment to early disease detection and prevention. Innovations in rapid molecular diagnostics, driven by research collaborations and government-funded programs, have positioned Denmark as a key market for cutting-edge diagnostic technologies.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Denmark hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account